Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease.
Exp Brain Res. 2018 May;236(5):1241-1250. doi: 10.1007/s00221-018-5210-x. Epub 2018 Feb 26.
Exp Brain Res. 2018.
PMID: 29480353